Cite
HARVARD Citation
Reich, K. et al. (2023). Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3. British journal of dermatology. pp. 208-217. [Online].